New prenatal test, chromosomal microarray, proposed as standard of care
A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant information than the current standard ...
Obstetrics & gynaecology
Dec 05, 2012 |
not rated yet |
0
|
Molecular knock-out alleviates Alzheimer's symptoms in mice
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have identified an enzyme as a possible target for the treatment of Alzheimer's disease. The protein ...
Alzheimer's disease & dementia
Nov 30, 2012 |
5 / 5 (4) |
1
|
Can a genetic variation in the vitamin D receptor protect against osteoporosis?
Osteoporosis, or reduced bone mineral density that can increase the risk of fractures, may affect as many as 30% of women and 12% of men worldwide. One risk factor for osteoporosis is vitamin D deficiency. ...
Genetics
Nov 29, 2012 |
not rated yet |
0
Protein injection points to muscular dystrophy treatment
Scientists have discovered that injecting a novel human protein into muscle affected by Duchenne muscular dystrophy significantly increases its size and strength, findings that could lead to a therapy akin to the use of insulin ...
Medical research
Nov 27, 2012 |
5 / 5 (2) |
0
|
Continued use of ADHD drugs may reduce criminal behavior, study says
(HealthDay)—For teens and adults who don't grow out of attention deficit hyperactivity disorder, staying on ADHD medications may help them stay out of trouble.
Attention deficit disorders
Nov 22, 2012 |
5 / 5 (2) |
1
|
Researchers excel in predicting cancer drug sensitivity
Researchers from Helsinki Institute for Information Technology HIIT and Institute for Molecular Medicine Finland FIMM have developed a triumphant solution for predicting responses of breast cancer cells to a set of cancer ...
Cancer
Nov 19, 2012 |
5 / 5 (1) |
0
Study shows large-scale genomic testing feasible, impacts therapy
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice for tumor specimens from NSCLC patients to be examined for EGFR mutations and ALK rearrangements ...
Cancer
Nov 15, 2012 |
not rated yet |
0
Rare genetic mutation triples Alzheimer's risk
A gene so powerful it nearly triples the risk of Alzheimer's disease has been discovered by an international team including researchers from Mayo Clinic. It is the most potent genetic risk factor for Alzheimer's identified ...
Alzheimer's disease & dementia
Nov 14, 2012 |
5 / 5 (1) |
0
|
Research breakthrough could halt melanoma metastasis
In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 ...
Cancer
Nov 14, 2012 |
4.8 / 5 (6) |
0
|
Drug shrinks brain tumors in children with tuberous sclerosis complex
A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC)—a genetic disease ...
Cancer
Nov 13, 2012 |
not rated yet |
0
|
Common enzyme deficiency may hinder plans to eradicate malaria
In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria, according to a ...
Diseases, Conditions, Syndromes
Nov 13, 2012 |
not rated yet |
0
Mutations in genes that modify DNA packaging result in Facioscapulohumeral Muscular Dystrophy
A recent finding by medical geneticists sheds new light on how Facioscapulohumeral Muscular Dystrophy develops and how it might be treated. More commonly known as FSHD, the devastating disease affects both ...
Genetics
Nov 11, 2012 |
4.5 / 5 (2) |
0
|
Stem cell scientists discover potential way to expand cells for use with patients
Canadian and Italian stem cell researchers have discovered a new "master control gene" for human blood stem cells and found that manipulating its levels could potentially create a way to expand these cells for clinical use.
Medical research
Nov 08, 2012 |
5 / 5 (2) |
0
|
New method helps link genomic variation to protein production
Scientists have adopted a novel laboratory approach for determining the effect of genetic variation on the efficiency of the biological process that translates a gene's DNA sequence into a protein, such as hemoglobin, according ...
Genetics
Nov 06, 2012 |
4.3 / 5 (3) |
0
|
Scientists find Achilles' heel of cancer cells
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arresting growth of cultured ...
Cancer
Nov 05, 2012 |
5 / 5 (6) |
0
|
